These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34413315)

  • 1. Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America.
    Herzog JS; Chavarri-Guerra Y; Castillo D; Abugattas J; Villarreal-Garza C; Sand S; Clague-Dehart J; Alvarez-Gómez RM; Wegman-Ostrosky T; Mohar A; Mora P; Del Toro-Valero A; Daneri-Navarro A; Rodriguez Y; Cruz-Correa M; Ashton-Prolla P; Alemar B; Mejia R; Gallardo L; Shaw R; Yang K; Cervantes A; Tsang K; Nehoray B; Barrera Saldana H; Neuhausen S; Weitzel JN
    NPJ Breast Cancer; 2021 Aug; 7(1):107. PubMed ID: 34413315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.
    Ossa CA; Torres D
    Oncologist; 2016 Jul; 21(7):832-9. PubMed ID: 27286788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
    ElBiad O; Laraqui A; El Boukhrissi F; Mounjid C; Lamsisi M; Bajjou T; Elannaz H; Lahlou AI; Kouach J; Benchekroune K; Oukabli M; Chahdi H; Ennaji MM; Tanz R; Sbitti Y; Ichou M; Ennibi K; Badaoui B; Sekhsokh Y
    BMC Cancer; 2022 Feb; 22(1):208. PubMed ID: 35216584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
    Villarreal-Garza C; Alvarez-Gómez RM; Pérez-Plasencia C; Herrera LA; Herzog J; Castillo D; Mohar A; Castro C; Gallardo LN; Gallardo D; Santibáñez M; Blazer KR; Weitzel JN
    Cancer; 2015 Feb; 121(3):372-8. PubMed ID: 25236687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel pathogenic variant in
    Laraqui A; Cavaillé M; Uhrhammer N; ElBiad O; Bidet Y; El Rhaffouli H; El Anaz H; Rahali DM; Kouach J; Guelzim K; Badaoui B; AlBouzidi A; Oukabli M; Tanz R; Sbitti Y; Ichou M; Ennibi K; Sekhsokh Y; Bignon YJ
    J Genomics; 2021; 9():43-54. PubMed ID: 34646395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
    Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
    BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.
    Dutil J; Golubeva VA; Pacheco-Torres AL; Diaz-Zabala HJ; Matta JL; Monteiro AN
    Breast Cancer Res Treat; 2015 Dec; 154(3):441-53. PubMed ID: 26564481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of germline
    Villarreal-Garza C; Ferrigno AS; Aranda-Gutierrez A; Frankel PH; Ruel NH; Fonseca A; Narod S; Chavarri-Guerra Y; Sifuentes E; Magallanes-Hoyos MC; Herzog J; Castillo D; Alvarez-Gomez RM; Mohar-Betancourt A; Weitzel JN
    Cancer Res Commun; 2021 Dec; 1(3):140-147. PubMed ID: 35875314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landscape of germline
    Ferreyra Y; Rosas G; Cock-Rada AM; Araujo J; Bravo L; Doimi F; Casas J; Clavo MLÁ; Pinto JA; Belmar-López C
    Front Oncol; 2023; 13():1227864. PubMed ID: 37664050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.
    Alemar B; Herzog J; Brinckmann Oliveira Netto C; Artigalás O; Schwartz IVD; Matzenbacher Bittar C; Ashton-Prolla P; Weitzel JN
    Cancer Genet; 2016 Sep; 209(9):417-422. PubMed ID: 27425403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients.
    Eoh KJ; Park JS; Park HS; Lee ST; Han J; Lee JY; Kim SW; Kim S; Kim YT; Nam EJ
    Gynecol Oncol; 2017 Apr; 145(1):137-141. PubMed ID: 28159408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.
    Euhus DM; Smith KC; Robinson L; Stucky A; Olopade OI; Cummings S; Garber JE; Chittenden A; Mills GB; Rieger P; Esserman L; Crawford B; Hughes KS; Roche CA; Ganz PA; Seldon J; Fabian CJ; Klemp J; Tomlinson G
    J Natl Cancer Inst; 2002 Jun; 94(11):844-51. PubMed ID: 12048272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients.
    Isiklar AD; Aliyeva L; Yesilyurt A; Soyder A; Basaran G
    Breast Cancer Res Treat; 2023 Nov; 202(2):297-304. PubMed ID: 37615792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
    Vogel KJ; Atchley DP; Erlichman J; Broglio KR; Ready KJ; Valero V; Amos CI; Hortobagyi GN; Lu KH; Arun B
    J Clin Oncol; 2007 Oct; 25(29):4635-41. PubMed ID: 17925560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing.
    Mitri ZI; Jackson M; Garby C; Song J; Giordano SH; Hortobágyi GN; Singletary CN; Hashmi SS; Arun BK; Litton JK
    Oncologist; 2015 Jun; 20(6):593-7. PubMed ID: 25948675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Practice Guidelines, BRCAPRO, and Genetic Counselor Estimates to Identify Germline BRCA1 and BRCA2 Mutations in Pancreatic Cancer.
    Grant RC; Holter S; Borgida A; Dhani NC; Hedley DW; Knox JJ; Akbari MR; Zogopoulos G; Gallinger S
    J Genet Couns; 2018 Aug; 27(4):988-995. PubMed ID: 29441441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients.
    Rao NY; Hu Z; Yu JM; Li WF; Zhang B; Su FX; Wu J; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 Aug; 116(3):563-70. PubMed ID: 18807178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients.
    Chavarri-Guerra Y; Hendricks CB; Brown S; Marcum C; Hander M; Segota ZE; Hake C; Sand S; Slavin TP; Hurria A; Soto-Perez-de-Celis E; Nehoray B; Blankstein KB; Blazer KR; Weitzel JN;
    J Am Geriatr Soc; 2019 May; 67(5):884-888. PubMed ID: 31012959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru.
    Abugattas J; Llacuachaqui M; Allende YS; Velásquez AA; Velarde R; Cotrina J; Garcés M; León M; Calderón G; de la Cruz M; Mora P; Royer R; Herzog J; Weitzel JN; Narod SA
    Clin Genet; 2015 Oct; 88(4):371-5. PubMed ID: 25256238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
    Cline MS; Liao RG; Parsons MT; Paten B; Alquaddoomi F; Antoniou A; Baxter S; Brody L; Cook-Deegan R; Coffin A; Couch FJ; Craft B; Currie R; Dlott CC; Dolman L; den Dunnen JT; Dyke SOM; Domchek SM; Easton D; Fischmann Z; Foulkes WD; Garber J; Goldgar D; Goldman MJ; Goodhand P; Harrison S; Haussler D; Kato K; Knoppers B; Markello C; Nussbaum R; Offit K; Plon SE; Rashbass J; Rehm HL; Robson M; Rubinstein WS; Stoppa-Lyonnet D; Tavtigian S; Thorogood A; Zhang C; Zimmermann M; ; Burn J; Chanock S; Rätsch G; Spurdle AB
    PLoS Genet; 2018 Dec; 14(12):e1007752. PubMed ID: 30586411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.